GB1343154A - Radioactive labelling device - Google Patents
Radioactive labelling deviceInfo
- Publication number
- GB1343154A GB1343154A GB2471771*A GB2471771A GB1343154A GB 1343154 A GB1343154 A GB 1343154A GB 2471771 A GB2471771 A GB 2471771A GB 1343154 A GB1343154 A GB 1343154A
- Authority
- GB
- United Kingdom
- Prior art keywords
- container
- resin
- microparticles
- radiotechnetium
- packing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000163 radioactive labelling Methods 0.000 title 1
- 239000011859 microparticle Substances 0.000 abstract 3
- 239000011347 resin Substances 0.000 abstract 3
- 229920005989 resin Polymers 0.000 abstract 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 abstract 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- 239000007788 liquid Substances 0.000 abstract 2
- 238000012856 packing Methods 0.000 abstract 2
- 239000002245 particle Substances 0.000 abstract 2
- 239000000243 solution Substances 0.000 abstract 2
- JKFYKCYQEWQPTM-UHFFFAOYSA-N 2-azaniumyl-2-(4-fluorophenyl)acetate Chemical compound OC(=O)C(N)C1=CC=C(F)C=C1 JKFYKCYQEWQPTM-UHFFFAOYSA-N 0.000 abstract 1
- 102000009027 Albumins Human genes 0.000 abstract 1
- 108010088751 Albumins Proteins 0.000 abstract 1
- 229920000856 Amylose Polymers 0.000 abstract 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 abstract 1
- 239000001828 Gelatine Substances 0.000 abstract 1
- 229920002527 Glycogen Polymers 0.000 abstract 1
- 102000001554 Hemoglobins Human genes 0.000 abstract 1
- 108010054147 Hemoglobins Proteins 0.000 abstract 1
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- 229910021612 Silver iodide Inorganic materials 0.000 abstract 1
- 239000004133 Sodium thiosulphate Substances 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- 239000011609 ammonium molybdate Substances 0.000 abstract 1
- APUPEJJSWDHEBO-UHFFFAOYSA-P ammonium molybdate Chemical compound [NH4+].[NH4+].[O-][Mo]([O-])(=O)=O APUPEJJSWDHEBO-UHFFFAOYSA-P 0.000 abstract 1
- 229940010552 ammonium molybdate Drugs 0.000 abstract 1
- 235000018660 ammonium molybdate Nutrition 0.000 abstract 1
- 239000011230 binding agent Substances 0.000 abstract 1
- 239000003638 chemical reducing agent Substances 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 229960004887 ferric hydroxide Drugs 0.000 abstract 1
- 239000000945 filler Substances 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 229940096919 glycogen Drugs 0.000 abstract 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
- IEECXTSVVFWGSE-UHFFFAOYSA-M iron(3+);oxygen(2-);hydroxide Chemical compound [OH-].[O-2].[Fe+3] IEECXTSVVFWGSE-UHFFFAOYSA-M 0.000 abstract 1
- 238000002372 labelling Methods 0.000 abstract 1
- 239000000314 lubricant Substances 0.000 abstract 1
- 239000004005 microsphere Substances 0.000 abstract 1
- 238000005065 mining Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000002285 radioactive effect Effects 0.000 abstract 1
- 229940045105 silver iodide Drugs 0.000 abstract 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 abstract 1
- 235000019345 sodium thiosulphate Nutrition 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
- 239000006228 supernatant Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 239000000080 wetting agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
- A61K51/1255—Granulates, agglomerates, microspheres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S206/00—Special receptacle or package
- Y10S206/828—Medicinal content
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S422/00—Chemical apparatus and process disinfecting, deodorizing, preserving, or sterilizing
- Y10S422/903—Radioactive material apparatus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2276570A | 1970-03-26 | 1970-03-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1343154A true GB1343154A (en) | 1974-01-10 |
Family
ID=21811314
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB2471771*A Expired GB1343154A (en) | 1970-03-26 | 1971-04-19 | Radioactive labelling device |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US3707353A (enExample) |
| JP (1) | JPS5127158B1 (enExample) |
| BE (1) | BE764814A (enExample) |
| CA (1) | CA948103A (enExample) |
| CH (1) | CH572734A5 (enExample) |
| DE (1) | DE2115066A1 (enExample) |
| FR (1) | FR2087863A5 (enExample) |
| GB (1) | GB1343154A (enExample) |
| IT (1) | IT972075B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7112927A (enExample) * | 1971-09-21 | 1973-03-23 | ||
| US4031198A (en) * | 1972-08-30 | 1977-06-21 | Minnesota Mining And Manufacturing Company | Technetium-labeled complexes, production and use thereof |
| US3926176A (en) * | 1973-08-15 | 1975-12-16 | Gen Electric | Radioactive gas-containing polymeric capsule |
| US4162142A (en) * | 1978-06-29 | 1979-07-24 | The United States Of America As Represented By The United States Department Of Energy | Tritium labeling of organic compounds deposited on porous structures |
| GB8310038D0 (en) * | 1983-04-13 | 1983-05-18 | Amersham Int Plc | Technetium-99 labelled tin colloid |
| US4765655A (en) * | 1986-04-22 | 1988-08-23 | Crihan Ioan G | Radioisotope marking of art objects in view of their rapid identification |
| AT503011B1 (de) * | 2006-02-14 | 2007-07-15 | Univ Wien Med | Synthesebehälter, synthesevorrichtung und syntheseverfahren zur herstellung einer pharmazeutisch aktiven substanz aus einer geeigneten vorläufersubstanz |
| DE102011079031A1 (de) * | 2011-07-12 | 2013-01-17 | Algeta Asa | Flüssigkeitsbehälter |
| EP2761623A4 (en) * | 2011-09-30 | 2016-01-20 | Ge Healthcare Ltd | PARTITIONED REACTION VESSELS |
-
1970
- 1970-03-26 US US22765A patent/US3707353A/en not_active Expired - Lifetime
-
1971
- 1971-03-25 DE DE19712115066 patent/DE2115066A1/de active Pending
- 1971-03-25 IT IT49305/71A patent/IT972075B/it active
- 1971-03-25 JP JP46017575A patent/JPS5127158B1/ja active Pending
- 1971-03-25 CH CH435871A patent/CH572734A5/xx not_active IP Right Cessation
- 1971-03-25 BE BE764814A patent/BE764814A/xx unknown
- 1971-03-25 CA CA108,744A patent/CA948103A/en not_active Expired
- 1971-03-25 FR FR7110718A patent/FR2087863A5/fr not_active Expired
- 1971-04-19 GB GB2471771*A patent/GB1343154A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| US3707353A (en) | 1972-12-26 |
| IT972075B (it) | 1974-05-20 |
| JPS5127158B1 (enExample) | 1976-08-11 |
| CH572734A5 (enExample) | 1976-02-27 |
| DE2115066A1 (de) | 1971-10-07 |
| FR2087863A5 (enExample) | 1971-12-31 |
| BE764814A (fr) | 1971-09-27 |
| CA948103A (en) | 1974-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1136194A (en) | Radioactive package and container therefor | |
| GB1343154A (en) | Radioactive labelling device | |
| Read | Studies of Red-Cell Volume and Turnover Using Radiochromium: Description of a New “Closed” Method of Red-Cell-Volume Measurement | |
| ES442017A1 (es) | Procedimiento para la produccion de dispositivos de suminis-tro farmaceuticamente microsellable. | |
| GB1186587A (en) | Device for Producing a Liquid having Radioactive Constituents | |
| ATE153963T1 (de) | Verpackung für stoffe zur aufgussbereitung | |
| GB1131546A (en) | Production of high-purity radioactive isotopes | |
| JPS62171671A (ja) | 培養液容器付き試料採取用タンポン | |
| GB1246540A (en) | Boron-rich fire-retardant composition | |
| GB1267304A (en) | Method for making filled capsules | |
| US3743714A (en) | Novel carrier preparations for injectable radioactive compositions | |
| GB1473236A (en) | Radioactive material generator | |
| Kleine et al. | The Early Loss of Radioactivity in Cr51Survival Curves: Destruction of Cells or Loss of the Label? | |
| US3801818A (en) | Radioactive generator with permeable closure | |
| Hušák et al. | Long-lived 99Tc in generator-produced 99mTc, its determination and significance | |
| GB1329545A (en) | Radioactive iodine.131 | |
| Welch et al. | Radiopharmaceuticals for neurological studies | |
| CN215460219U (zh) | 一种医用暂存补液袋 | |
| RU2315624C2 (ru) | Способ получения наноколлоида для приготовления радиофармпрепаратов | |
| US2423240A (en) | Method for retaining the radioactivity of liquids intended for injections | |
| Hawker et al. | The preparation and use of 113m-Indium oxine as a platelet label | |
| GB1231159A (enExample) | ||
| GB1210938A (en) | Production of a pharmaceutically acceptable saline solution containing radioactive gas and use thereof | |
| Billinghurst et al. | In vitro study of the mechanism of the in vivo red blood cell labeling technique | |
| Deckart et al. | Absorption delay of encapsulated 131I in test and therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PLNP | Patent lapsed through nonpayment of renewal fees |